PRR-mediated adjuvants have traditionally been associated with enhancing Th1 or Th17 immunity, which is particularly important in the context of food allergies such as peanut allergy as it downregulates the Th2 response commonly found in IgE-mediated allergy [40,41]. Here, IGHE is linked to allergic disease.